A client taking capivasertib develops intense thirst, frequent urination, nausea, abdominal pain, deep rapid respirations, and positive serum ketones. Which action is the priority?
1Give the next dose with carbohydrate and recheck serum glucose in one hour.
2Continue capivasertib while arranging an oncology visit within several days.
3Treat the nausea and abdominal pain, then repeat ketone testing after the next dose.
4Hold capivasertib and obtain urgent evaluation and treatment for suspected ketoacidosis.✓ Correct answer
Explanation
Capivasertib can cause severe hyperglycemia, diabetic ketoacidosis, and fatal metabolic complications. Suspected ketoacidosis requires immediate withholding and urgent medical management.
Quick answer Treat hyperglycemic symptoms plus ketones as suspected ketoacidosis.
Why this is correct Polyuria, polydipsia, abdominal symptoms, deep respirations, and ketones form a metabolic-emergency pattern. Routine delay or additional drug exposure can worsen the decompensation.
Easy analogy or mental picture Build a medication-safety chain: identify the changing cue, connect it to the labeled toxicity or interaction, interrupt preventable exposure, stabilize the client, and verify a measurable response.
NCLEX decision rule Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.
Why the other choices are wrong Options that continue a suspect exposure, normalize a labeled danger cue, or delay escalation leave the client at risk.
References
1DailyMed: TRUQAP (capivasertib)Severe hyperglycemia and ketoacidosis recognition, immediate interruption, glucose monitoring, diarrhea, and cutaneous toxicity
Oncology medication-safety reviewVerify indication, current assessment, laboratory and oxygen trends, interactions, urgent toxicity cues, authorized action, and measurable follow-up.